Dr. Jakub Trefler is a rheumatologist and clinical researcher whose work focuses on systemic sclerosis and other autoimmune connective tissue diseases. His research interests include disease biomarkers, health-related quality of life, immunopathogenesis, and the development of innovative therapeutic strategies for rheumatic diseases. He is actively involved in clinical trials and translational research aimed at improving patient outcomes. His recent studies have explored the relationships between immunological markers, disease manifestations, and patient-reported outcomes in systemic sclerosis, with a particular focus on identifying clinically relevant biomarkers and novel therapeutic targets. Dr. Trefler collaborates with international research groups and contributes to the advancement of evidence-based rheumatology through clinical and academic research.
Dr. Jakub Trefler is a rheumatologist and clinical researcher whose work focuses on systemic sclerosis and other autoimmune connective tissue diseases. His research interests include disease biomarkers, health-related quality of life, immunopathogenesis, and the development of innovative therapeutic strategies for rheumatic diseases. He is actively involved in clinical trials and translational research aimed at improving patient outcomes. His recent studies have explored the relationships between immunological markers, disease manifestations, and patient-reported outcomes in systemic sclerosis, with a particular focus on identifying clinically relevant biomarkers and novel therapeutic targets. Dr. Trefler collaborates with international research groups and contributes to the advancement of evidence-based rheumatology through clinical and academic research.